Clinical trial
Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women…
NCT00436917 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00436917 |
|---|---|
| Title | Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer |
| Official title | Zoledronic Acid for Treatment of Osteopenia and Osteoporosis in Women With Primary Breast Cancer Undergoing Adjuvant Aromatase Inhibitor (Letrozole) Therapy |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Breast Cancer, Osteoporosis |
| Intervention type | Drug, Procedure |
| Interventions | zoledronic acid, Letrozole as adjuvant therapy |
| Enrollment | 60 |
| Start date | Apr 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | May 9, 2016 |
| First posted | Feb 19, 2007 |
| Last update posted | Sep 11, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: